Document is current

Any future updates will be listed below

Cost-Effectiveness of Apixaban vs. Other New Oral Anticoagulants for the Prevention of Stroke: An Analysis on Patients with Non-Valvular Atrial Fibrillation in the Greek Healthcare Setting

Crossref DOI link: https://doi.org/10.1007/s40261-015-0321-7

Published Online: 2015-09-18

Published Print: 2015-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark